EyeGene Inc.

KOSDAQ:A185490 Rapporto sulle azioni

Cap. di mercato: ₩77.3b

EyeGene Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Won-Il Yoo

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO24.4yrs
Proprietà del CEO4.8%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Nessun aggiornamento

Recent updates

Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Jul 26
Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

Mar 29
Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Feb 01
EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

Dec 07
Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

AMMINISTRATORE DELEGATO

Won-Il Yoo

24.4yrs

Mandato

Mr. Won-Il Yoo has been Chief Executive Officer of EyeGene, Inc. since June 2000. Mr. Yoo has directed EyeGene's initial financing, set-up, recruiting, R&D and business development. He has over 12 years re...